Common Stock, Shares, Outstanding of NovoCure Ltd from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NovoCure Ltd quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2014 to Q3 2025.
  • NovoCure Ltd Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 111,979,981, a 3.6% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NovoCure Ltd Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 111,979,981 +3,879,589 +3.6% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 111,798,690 +3,784,860 +3.5% 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 111,482,600 +3,878,826 +3.6% 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 108,516,819 +1,441,065 +1.3% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 108,100,392 +1,352,122 +1.3% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 108,013,830 +1,408,499 +1.3% 30 Jun 2024 10-Q 25 Jul 2024 2024 Q2
Q1 2024 107,603,774 +1,416,612 +1.3% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 107,075,754 +2,026,343 +1.9% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 106,748,270 +1,805,329 +1.7% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 106,605,331 +1,877,646 +1.8% 30 Jun 2023 10-Q 27 Jul 2023 2023 Q2
Q1 2023 106,187,162 +1,628,074 +1.6% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 105,049,411 +1,078,148 +1% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 104,942,941 +1,125,375 +1.1% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 104,727,685 +1,086,447 +1% 30 Jun 2022 10-Q 28 Jul 2022 2022 Q2
Q1 2022 104,559,088 +1,371,628 +1.3% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 103,971,263 +1,636,987 +1.6% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 103,817,566 +2,089,239 +2.1% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 103,641,238 +2,620,517 +2.6% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 103,187,460 +2,824,487 +2.8% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 102,334,276 +2,805,841 +2.8% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 101,728,327 +2,779,392 +2.8% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 101,020,721 +3,161,845 +3.2% 30 Jun 2020 10-Q/A 02 Oct 2020 2020 Q2
Q1 2020 100,362,973 +4,670,176 +4.9% 31 Mar 2020 10-Q/A 02 Oct 2020 2020 Q1
Q4 2019 99,528,435 +6,274,250 +6.7% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 98,948,935 +5,941,091 +6.4% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 97,858,876 +5,355,603 +5.8% 30 Jun 2019 10-Q 25 Jul 2019 2019 Q2
Q1 2019 95,692,797 +5,293,896 +5.9% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 93,254,185 +3,776,153 +4.2% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 93,007,844 +3,652,165 +4.1% 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 92,503,273 +3,873,068 +4.4% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 90,398,901 +2,265,535 +2.6% 31 Mar 2018 10-Q 26 Apr 2018 2018 Q1
Q4 2017 89,478,032 +2,411,586 +2.8% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 89,355,679 +3,580,476 +4.2% 30 Sep 2017 10-Q 26 Oct 2017 2017 Q3
Q2 2017 88,630,205 +2,855,431 +3.3% 30 Jun 2017 10-Q 27 Jul 2017 2017 Q2
Q1 2017 88,133,366 +3,706,646 +4.4% 31 Mar 2017 10-Q 27 Apr 2017 2017 Q1
Q4 2016 87,066,446 +3,287,865 +3.9% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q3 2016 85,775,203 +73,342,910 +590% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 85,774,774 30 Jun 2016 10-Q 28 Jul 2016 2016 Q2
Q1 2016 84,426,720 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 83,778,581 +70,347,167 +524% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 12,432,293 30 Sep 2015 10-Q 27 Oct 2015 2015 Q3
Q4 2014 13,431,414 31 Dec 2014 10-K 01 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.